NPA filed two petitions with the U.S. Court of Appeals on November 11, 2021 and December 7, 2021 arguing the rule would slow delivery times and drive-up costs for consumers, retailers and manufacturers.
Employers Could Face “Mass Exodus of Employees”
NPA Sues FDA: Asks Courts to Block Unlawful Action in NAC Situation Calls FDA Actions on NAC a “Regulatory Sneak Attack”
WASHINGTON, D.C. – The Natural Products Association (NPA) filed a lawsuit against the Food and Drug Administration (NPA) requesting that the agency cease its unlawful retroactive application of the Food, Drug, and Cosmetic Act against N-acetyl-L-cysteine (“NAC”).The full lawsuit can…
Biden Admin’s Vaccine Mandate Will Have Immediate Adverse Impact on Natural Products Industry, Says NPA
NPA Asks U.S. Court of Appeals to Declare Mandate Unlawful
Natural Products Association Statement on Nomination of Robert Califf, M.D., To Lead Food and Drug Administration
NPA President and CEO Dr. Daniel Fabricant, Ph.D., released the following statement in response to the nomination of Robert Califf, M.D., to lead the Food and Drug Administration (FDA).
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.